Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UPA followed by desogestrel crossover contraceptive interaction study
NL-OMON39702Active, not recruiting
- Sponsor
- HRA Pharma
- Start
- Feb 2013
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial in contraception comparing UPA followed by desogestrel, UPA followed by placebo and Placebo followed by desogestrel (3 arms). Primary endpoint: Contraceptive effect within 21-day treatment period. Started Feb 2013; status: active, not recruiting.
02
Drugs
ulipristaldesogestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NL-OMON39702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39702.